MedTrace Logo

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

NCT00312442 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2010-06-02

No results posted yet for this study

Summary

The aim of this clinical trial is to evaluate the efficacy and safety of the WST09-mediated vascular-targeted photodynamic therapy (VTP) in patients with localized prostate cancer recurrent after external radiation therapy or temporary (High Dose Rate, or HDR) brachytherapy.

Conditions

Interventions

DRUG

Treatment with WST09 Vascular Photodynamic therapy

Sponsors & Collaborators

  • STEBA France

    lead INDUSTRY

Principal Investigators

  • John Trachtenberg, MD FRCS(C) · University Health Network, Princess Margaret Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2008-07-31
Completion
2009-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00312442 on ClinicalTrials.gov